Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial

Fig. 2

a Mean change in height SDS at week 52 from baseline b Height SDS over time. P-value was obtained from Paired t-test. b The lower and upper boundaries are the 25th percentile and the 75th percentile, respectively. The horizontal line in the box shows the median. Filled squares are mean values. SDS, standard deviation score; CI, confidence interval; SE, standard error

Back to article page